FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2981928411> ?p ?o ?g. }

• W2981928411 endingPage "1777" @default.
• W2981928411 startingPage "1777" @default.
• W2981928411 abstract "Immune checkpoint inhibitor (ICI) therapy has revolutionized the management of various cancers with previously poor prognosis. Despite its great efficacy, the therapy is associated with a wide spectrum of immune-related adverse events (irAE) including neurological symptoms which can affect all parts of the central and peripheral nervous system. Even though these events are rare, they are of high relevance as the rate of residual symptoms or even fatal outcomes is remarkable. To provide a detailed overview of neurological adverse events associated with immune checkpoint-inhibitor therapy we conducted a literature search. While focusing on ipilimumab, nivolumab, and pembrolizumab therapy, all available case reports as well as larger case series and clinical trials have been considered. Eighty-two case reports about checkpoint-inhibitor therapy induced symptoms of the peripheral nervous system have been published, while only 43 case reports addressed central nervous system abnormalities. The frequency of immune checkpoint-inhibitor therapy inducing neurological adverse events is about 1% in larger studies. Especially neuromuscular adverse events exhibit distinct clinical and diagnostic characteristics. Additionally, several affected patients presented with overlap-syndromes, which means that symptoms and diagnostic findings indicating myositis, myasthenia gravis, and neuropathy were present in one individual patient at the same time. Thus, neurological and particularly neuromuscular adverse events of immune checkpoint-inhibitor therapy may constitute a new disease entity." @default.
• W2981928411 created "2019-11-01" @default.
• W2981928411 creator A5001155888 @default.
• W2981928411 creator A5007665367 @default.
• W2981928411 creator A5015081105 @default.
• W2981928411 creator A5026803534 @default.
• W2981928411 creator A5043723659 @default.
• W2981928411 creator A5084108111 @default.
• W2981928411 date "2019-10-24" @default.
• W2981928411 modified "2023-10-10" @default.
• W2981928411 title "Neurological Immune Related Adverse Events Associated with Nivolumab, Ipilimumab, and Pembrolizumab Therapy—Review of the Literature and Future Outlook" @default.
• W2981928411 cites W1519521580 @default.
• W2981928411 cites W1556990476 @default.
• W2981928411 cites W1969965329 @default.
• W2981928411 cites W1985648558 @default.
• W2981928411 cites W1990675339 @default.
• W2981928411 cites W2040190056 @default.
• W2981928411 cites W2046972425 @default.
• W2981928411 cites W2056535502 @default.
• W2981928411 cites W2076067786 @default.
• W2981928411 cites W2095826876 @default.
• W2981928411 cites W2096623062 @default.
• W2981928411 cites W2097995306 @default.
• W2981928411 cites W2101653483 @default.
• W2981928411 cites W2110246157 @default.
• W2981928411 cites W2116548718 @default.
• W2981928411 cites W2116607009 @default.
• W2981928411 cites W2138578705 @default.
• W2981928411 cites W2140419562 @default.
• W2981928411 cites W2143163879 @default.
• W2981928411 cites W2157118336 @default.
• W2981928411 cites W2160834915 @default.
• W2981928411 cites W2161550811 @default.
• W2981928411 cites W2162519330 @default.
• W2981928411 cites W2177843344 @default.
• W2981928411 cites W2260067559 @default.
• W2981928411 cites W2265285917 @default.
• W2981928411 cites W2329842261 @default.
• W2981928411 cites W2332091461 @default.
• W2981928411 cites W2338423971 @default.
• W2981928411 cites W2463159167 @default.
• W2981928411 cites W2466345199 @default.
• W2981928411 cites W2490233753 @default.
• W2981928411 cites W2532352313 @default.
• W2981928411 cites W2546740014 @default.
• W2981928411 cites W2547133566 @default.
• W2981928411 cites W2550419061 @default.
• W2981928411 cites W2560367415 @default.
• W2981928411 cites W2569887568 @default.
• W2981928411 cites W2572174216 @default.
• W2981928411 cites W2605603145 @default.
• W2981928411 cites W2612010935 @default.
• W2981928411 cites W2625359171 @default.
• W2981928411 cites W2732739205 @default.
• W2981928411 cites W2743419024 @default.
• W2981928411 cites W2747440871 @default.
• W2981928411 cites W2751866898 @default.
• W2981928411 cites W2762554941 @default.
• W2981928411 cites W2775518969 @default.
• W2981928411 cites W2791053446 @default.
• W2981928411 cites W2793167197 @default.
• W2981928411 cites W2793180707 @default.
• W2981928411 cites W2793296697 @default.
• W2981928411 cites W2794109313 @default.
• W2981928411 cites W2794437786 @default.
• W2981928411 cites W2886247697 @default.
• W2981928411 cites W2887907748 @default.
• W2981928411 cites W2892727895 @default.
• W2981928411 cites W2899240190 @default.
• W2981928411 cites W2901974641 @default.
• W2981928411 cites W2916937155 @default.
• W2981928411 cites W2920986063 @default.
• W2981928411 cites W2937702718 @default.
• W2981928411 cites W2940759533 @default.
• W2981928411 cites W2945188228 @default.
• W2981928411 cites W2946800373 @default.
• W2981928411 cites W2951456450 @default.
• W2981928411 cites W865168492 @default.
• W2981928411 doi "https://doi.org/10.3390/jcm8111777" @default.
• W2981928411 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6912719" @default.
• W2981928411 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31653079" @default.
• W2981928411 hasPublicationYear "2019" @default.
• W2981928411 type Work @default.
• W2981928411 sameAs 2981928411 @default.
• W2981928411 citedByCount "80" @default.
• W2981928411 countsByYear W29819284112020 @default.
• W2981928411 countsByYear W29819284112021 @default.
• W2981928411 countsByYear W29819284112022 @default.
• W2981928411 countsByYear W29819284112023 @default.
• W2981928411 crossrefType "journal-article" @default.
• W2981928411 hasAuthorship W2981928411A5001155888 @default.
• W2981928411 hasAuthorship W2981928411A5007665367 @default.
• W2981928411 hasAuthorship W2981928411A5015081105 @default.
• W2981928411 hasAuthorship W2981928411A5026803534 @default.
• W2981928411 hasAuthorship W2981928411A5043723659 @default.
• W2981928411 hasAuthorship W2981928411A5084108111 @default.
• W2981928411 hasBestOaLocation W29819284111 @default.
• W2981928411 hasConcept C126322002 @default.

• next